Condrosulf’s Latest Trial Results – The FACTS Trial
The Finger osteoArthritis Chondroitin Treatment Study (FACTS) was completed in 2010 and the results published in the American College of Rheumatology’s medical journal Arthritis & Rheumatism Volume 63, Issue 11, pages 3383–3391, November 2011.
While the trial results were first published in November 2011 the full text has only become freely available to practitioners and members of the public since November 2012.
The trial conclusion reads “Condrosulf (CS) improves hand pain and function in patients with symptomatic OA of the hand and shows a good safety profile.”
The trial results were announced in an American College of Rheumatology press release.
There was commentary from many medical blogs. One of the most widely read is here.
Condrosulf is a medical grade chondroitin with a large body of peer reviewed published medical literature to support its claims to efficacy.
While many health supplement/nutraceutical chondroitins use Condrosulf’s literature in marketing campaigns there is no recognition by world leading researchers, or the manufacturers of Condrosulf, IBSA, as to any suggested similarity between Condrosulf’s 98% pure chondroitin 4 & 6 isomer formulation and the large number of health supplement/nutraceutical chondroitins heavily promoted to consumers in many countries throughout the world.
Condrosulf has the alternative spelling of Chondrosulf or Condrosulf depending on its country of distribution. Australian Condrosulf is Swiss Condrosulf overlay labelled with English language labels. It is drawn from Swiss Condrosulf stocks and still has Swiss regulatory authority (Swissmedic) markings on the packet in addition to the Australian regulatory authority’s (TGA)’s markings.
Condrosulf Australia customers can be doubly assured they are purchasing safe, genuine product that has been through two of the most rigorous medical regulatory authorities in the world.
The Condrosulf formulation used in the FACTS hand and finger arthritis trial is now available for purchase from this website.
Other clinical trials and medical literature related to the use of Condrosulf for hand and finger arthritis are as follows:
Verbruggen, G., Goemaere, S., Veys, E. M. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis and Cartilage 6 (Suppl. A): 37 – 38; 1998.
Verbruggen, G., Veys, E. M. Influence of Chondroitin 4&6 Sulfate on finger osteoarthritis in a double-blind, controlled study versus placebo. Litera Rheumatologica 24: 43 – 47; 1998.